drugset / Trial / NCT02765815

A Comparison of Exparel Local Anesthetic in Total Knee Arthroplasty (TKA) Patients

NCT02765815

Phase 4 Withdrawn Holy Cross Hospital, Florida
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a prospective, single-center, single-blinded, randomized, case-control study. The study is conducted by a single investigator at an orthopedic surgery institute, with a minimum 6 week post operative follow-up period of TKA patients who receive Exparel compared with the surgeon's standard method (detailed below) for pain management intraoperatively.

Timeline

Start
2016-02
Primary completion
2017-01
Completion
2017-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 0.25 %
Comparator Bupivacaine Other / unclassified 0.5 %
Comparator Bupivacaine Other / unclassified 266 mg
Comparator Epinephrine Other / unclassified
Comparator Ketorolac Other / unclassified 30 mg
Comparator Morphine Other / unclassified 10 mg

Indications